Justin Adam Smith, Director at Journey Medical Corp (DERM), bought 30,000 shares at $3.47 ($104K) on 2024-03-22, disclosed to the SEC on 2024-03-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.